Back

Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Pulmonary hypertension: pre-clinical Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ana Garcia-Alvarez

Hospital Clinic, University of Barcelona, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Insulin resistance genetic susceptibility drives pulmonary arterial hypertension through monocyte metabolic reprogramming and immune dysregulation
Mr S. Hou (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Interleukin-22–STAT3 Signaling Preserves Structural Integrity in the Pressure-Overloaded Right Ventricle
Doctor K. Shibao (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Prophylactic ranolazine and trimetazidine attenuate right ventricular dysfunction and improve exercise capacity in experimental pulmonary hypertension
Doctor A. Oz (Istanbul, TR) Miss S. Asal (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Myo-inositol trispyrophosphate improves oxygen delivery and right ventricular function in rat pressure overload model
Doctor M. Maczewski (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Targeting the PSMB9–NGAL/MMP9 Axis: a novel neutrophil-driven mechanism and precision target for vascular remodeling in PAH
Associate Professor X. He (Guangzhou, CN)
Abstract Slides

Access the full session

Session thumbnail
Pulmonary hypertension: pre-clinical

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Metabolic syndrome contributes to the pulmonary arterial dysfunction in pulmonary hypertension in heart failure with preserved ejection fraction
31 August 2020
thumbnail
Congress Presentation
Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
9 December 2021
thumbnail
Congress Presentation
CMR feature tracking cloud assess right ventricular functional reserve with pulmonary arterial hypertension
6 May 2021
thumbnail
Congress Presentation
Metabolic impact of empagliflozin in patients with acute decompensated heart failure:A secondary analysis of the EMPAG-HF trial
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources